Home / News / Event #1115898 SEC EDGAR published this disclosure on 2026-09-09. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗ accession 0001610717-26-000409
acquired disposed A
code M
direct or indirect D
form 4
is derivative false
issuer name Ascendis Pharma A/S
label Exercise of derivative
Source record & verification Dates, provenance and technical details
Context links are based on the recorded entity type Recorded payload Structured source data
Recorded payload JSON payload as stored after parsing {
"accession": "0001610717-26-000409",
"acquired_disposed": "A",
"code": "M",
"direct_or_indirect": "D",
"form": "4",
"is_derivative": false,
"issuer_name": "Ascendis Pharma A/S",
"label": "Exercise of derivative",
"person_name": "Bodenhoff Mads",
"price": 110,
"role": "PAO",
"security": "Ordinary Shares",
"shares": 3000,
"shares_owned_after": 3000,
"source_path": "edgar/data/1612042/0001610717-26-000409.txt",
"ticker": "ASND",
"transaction_date": "2026-09-08",
"value": 330000
}
Evidence-based analysis facts, provenance and explicit model coverage Descriptive evidence from the stored source record; it is not advice, a forecast or a legal conclusion.